$SPRO Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Spero Therapeutics, Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of all insider trading transactions in Spero Therapeutics, Inc.. Get notifications about new insider transactions in Spero Therapeutics, Inc. for free.

Page:   1 2 next >

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 10 2021SPROSpero Therapeutics ...Aquilo Capital Management, LLC10% OwnerSellS21.743,00065,2153,829,2093.8 M to 3.8 M (-0.08 %)
Feb 04 2021SPROSpero Therapeutics ...Aquilo Capital Management, LLC10% OwnerSellS18.9934,144648,2553,832,2093.9 M to 3.8 M (-0.88 %)
Feb 04 2021SPROSpero Therapeutics ...Aquilo Capital Management, LLC10% OwnerSellS18.9829,354557,1013,866,3533.9 M to 3.9 M (-0.75 %)
Feb 04 2021SPROSpero Therapeutics ...Aquilo Capital Management, LLC10% OwnerSellS18.9922,841433,7713,895,7073.9 M to 3.9 M (-0.58 %)
Feb 04 2021SPROSpero Therapeutics ...Aquilo Capital Management, LLC10% OwnerSellS19.2413,661262,8613,918,5483.9 M to 3.9 M (-0.35 %)
Feb 03 2021SPROSpero Therapeutics ...Keutzer TimothyChief Development O ...Option ExerciseA19.1857,4321,101,54657,432
Feb 03 2021SPROSpero Therapeutics ...Larkin CristinaChief Operating Off ...Option ExerciseA19.1857,4321,101,54657,432
Feb 03 2021SPROSpero Therapeutics ...Mahadevia AnkitSee RemarksOption ExerciseA19.18179,3193,439,338179,319
Feb 03 2021SPROSpero Therapeutics ...Melnick David A.Chief Medical Offic ...Option ExerciseA19.1857,4321,101,54657,432
Jan 06 2021SPROSpero Therapeutics ...Smith CynthiaDirectorOption ExerciseA17.932,62947,1382,629
Jan 06 2021SPROSpero Therapeutics ...THOMAS FRANK EDirectorOption ExerciseA17.931,31423,5601,314
Jan 06 2021SPROSpero Therapeutics ...Deshpande MilindDirectorOption ExerciseA17.932,62947,1382,629
Dec 18 2020SPROSpero Therapeutics ...Aquilo Capital Management, LLC10% OwnerSellS18.81250,0004,703,2253,932,2094.2 M to 3.9 M (-5.98 %)
Dec 18 2020SPROSpero Therapeutics ...Aquilo Capital Management, LLC10% OwnerSellS18.6214,933278,0354,182,2094.2 M to 4.2 M (-0.36 %)
Nov 10 2020SPROSpero Therapeutics ...Aquilo Capital Management, LLC10% OwnerSellS13.77125,9001,734,0714,197,1424.3 M to 4.2 M (-2.91 %)
Nov 06 2020SPROSpero Therapeutics ...Aquilo Capital Management, LLC10% OwnerSellS13.775,00068,8744,323,0424.3 M to 4.3 M (-0.12 %)
Nov 06 2020SPROSpero Therapeutics ...Aquilo Capital Management, LLC10% OwnerSellS13.9896,6001,350,3334,328,0424.4 M to 4.3 M (-2.18 %)
Nov 06 2020SPROSpero Therapeutics ...Aquilo Capital Management, LLC10% OwnerSellS14.2672,5001,033,7414,424,6424.5 M to 4.4 M (-1.61 %)
Nov 05 2020SPROSpero Therapeutics ...Mahadevia AnkitCEO and PresidentOption ExerciseM5.907,37043,483494,809
Nov 05 2020SPROSpero Therapeutics ...Mahadevia AnkitCEO and PresidentOption ExerciseM5.902,13712,608502,179
Nov 05 2020SPROSpero Therapeutics ...Mahadevia AnkitCEO and PresidentSellS14.437,370106,33565,81773.2 K to 65.8 K (-10.07 %)
Nov 05 2020SPROSpero Therapeutics ...Mahadevia AnkitCEO and PresidentBuyM5.907,37043,48373,18765.8 K to 73.2 K (+11.20 %)
Nov 05 2020SPROSpero Therapeutics ...Mahadevia AnkitCEO and PresidentSellS14.272,13730,49065,81768 K to 65.8 K (-3.14 %)
Nov 05 2020SPROSpero Therapeutics ...Mahadevia AnkitCEO and PresidentBuyM5.902,13712,60867,95465.8 K to 68 K (+3.25 %)
Oct 27 2020SPROSpero Therapeutics ...FORMELA JEAN FRANCOISDirectorOption ExerciseA13.527,500101,4007,500
Oct 27 2020SPROSpero Therapeutics ...THOMAS FRANK EDirectorOption ExerciseA13.527,500101,4007,500
Oct 27 2020SPROSpero Therapeutics ...Smith CynthiaDirectorOption ExerciseA13.527,500101,4007,500
Oct 27 2020SPROSpero Therapeutics ...Jackson Scott ThomasDirectorOption ExerciseA13.527,500101,4007,500
Oct 27 2020SPROSpero Therapeutics ...Deshpande MilindDirectorOption ExerciseA13.527,500101,4007,500
Oct 27 2020SPROSpero Therapeutics ...Mahadevia AnkitCEO and PresidentOption ExerciseM5.9020118504,316
Oct 27 2020SPROSpero Therapeutics ...Mahadevia AnkitCEO and PresidentSellS14.252028565,81765.8 K to 65.8 K (-0.03 %)
Oct 27 2020SPROSpero Therapeutics ...Mahadevia AnkitCEO and PresidentBuyM5.902011865,83765.8 K to 65.8 K (+0.03 %)
Oct 27 2020SPROSpero Therapeutics ...VINK PATRICK V.J.J.DirectorOption ExerciseA13.527,500101,4007,500
Oct 27 2020SPROSpero Therapeutics ...Pottage John C JrDirectorOption ExerciseA13.527,500101,4007,500
Sep 10 2020SPROSpero Therapeutics ...Mahadevia AnkitCEO and PresidentOption ExerciseM5.907744,567518,808
Sep 10 2020SPROSpero Therapeutics ...Mahadevia AnkitCEO and PresidentSellS14.2577411,03065,81766.6 K to 65.8 K (-1.16 %)
Sep 10 2020SPROSpero Therapeutics ...Mahadevia AnkitCEO and PresidentBuyM5.907744,56766,59165.8 K to 66.6 K (+1.18 %)
Sep 10 2020SPROSpero Therapeutics ...Mahadevia AnkitCEO and PresidentOption ExerciseM5.907744,567518,808
Sep 10 2020SPROSpero Therapeutics ...Mahadevia AnkitCEO and PresidentSellS14.2577411,03065,81766.6 K to 65.8 K (-1.16 %)
Sep 10 2020SPROSpero Therapeutics ...Mahadevia AnkitCEO and PresidentBuyM5.907744,56766,59165.8 K to 66.6 K (+1.18 %)
Jul 09 2020SPROSpero Therapeutics ...Mahadevia AnkitCEO and PresidentOption ExerciseM5.902,29313,529519,582
Jul 09 2020SPROSpero Therapeutics ...Mahadevia AnkitCEO and PresidentOption ExerciseM5.907544,449521,875
Jul 09 2020SPROSpero Therapeutics ...Mahadevia AnkitCEO and PresidentSellS14.312,29332,80765,81768.1 K to 65.8 K (-3.37 %)
Jul 09 2020SPROSpero Therapeutics ...Mahadevia AnkitCEO and PresidentBuyM5.902,29313,52968,11065.8 K to 68.1 K (+3.48 %)
Jul 09 2020SPROSpero Therapeutics ...Mahadevia AnkitCEO and PresidentSellS14.2575410,74565,81766.6 K to 65.8 K (-1.13 %)
Jul 09 2020SPROSpero Therapeutics ...Mahadevia AnkitCEO and PresidentBuyM5.907544,44966,57165.8 K to 66.6 K (+1.15 %)
Jun 29 2020SPROSpero Therapeutics ...Mahadevia AnkitCEO and PresidentOption ExerciseM5.902,64215,588522,629
Jun 29 2020SPROSpero Therapeutics ...Mahadevia AnkitCEO and PresidentOption ExerciseM5.903,88022,892525,271
Jun 29 2020SPROSpero Therapeutics ...Mahadevia AnkitCEO and PresidentOption ExerciseM5.908,04547,466529,151
Jun 29 2020SPROSpero Therapeutics ...Mahadevia AnkitCEO and PresidentOption ExerciseM5.902,61315,417537,196
Jun 29 2020SPROSpero Therapeutics ...Mahadevia AnkitCEO and PresidentSellS14.252,64237,65065,81768.5 K to 65.8 K (-3.86 %)
Jun 29 2020SPROSpero Therapeutics ...Mahadevia AnkitCEO and PresidentBuyM5.902,64215,58868,45965.8 K to 68.5 K (+4.01 %)
Jun 29 2020SPROSpero Therapeutics ...Mahadevia AnkitCEO and PresidentSellS14.283,88055,42065,81769.7 K to 65.8 K (-5.57 %)
Jun 29 2020SPROSpero Therapeutics ...Mahadevia AnkitCEO and PresidentBuyM5.903,88022,89269,69765.8 K to 69.7 K (+5.90 %)
Jun 29 2020SPROSpero Therapeutics ...Mahadevia AnkitCEO and PresidentSellS14.338,045115,26465,81773.9 K to 65.8 K (-10.89 %)
Jun 29 2020SPROSpero Therapeutics ...Mahadevia AnkitCEO and PresidentBuyM5.908,04547,46673,86265.8 K to 73.9 K (+12.22 %)
Jun 29 2020SPROSpero Therapeutics ...Mahadevia AnkitCEO and PresidentSellS14.302,61337,36565,81768.4 K to 65.8 K (-3.82 %)
Jun 29 2020SPROSpero Therapeutics ...Mahadevia AnkitCEO and PresidentBuyM5.902,61315,41768,43065.8 K to 68.4 K (+3.97 %)
Jun 23 2020SPROSpero Therapeutics ...Jackson Scott ThomasDirectorOption ExerciseA13.9415,000209,10015,000
Feb 03 2020SPROSpero Therapeutics ...Melnick David A.Chief Medical Offic ...Option ExerciseA9.3455,000513,70055,000
Feb 03 2020SPROSpero Therapeutics ...Mahadevia AnkitCEO and PresidentOption ExerciseA9.34180,0001,681,200180,000
Feb 03 2020SPROSpero Therapeutics ...Larkin CristinaChief Operating Off ...Option ExerciseA9.3455,000513,70055,000
Feb 03 2020SPROSpero Therapeutics ...Keutzer TimothyChief Development O ...Option ExerciseA9.3455,000513,70055,000
Jan 06 2020SPROSpero Therapeutics ...THOMAS FRANK EDirectorOption ExerciseA9.872,70426,6882,704
Jan 06 2020SPROSpero Therapeutics ...FORMELA JEAN FRANCOISDirectorOption ExerciseA9.875,40853,3775,408
Jan 06 2020SPROSpero Therapeutics ...VINK PATRICK V.J.J.DirectorOption ExerciseA9.875,40853,3775,408
Jan 06 2020SPROSpero Therapeutics ...Deshpande MilindDirectorOption ExerciseA9.875,40853,3775,408
Jun 05 2019SPROSpero Therapeutics ...Smith CynthiaDirectorOption ExerciseA10.676,07364,7996,073
Jun 05 2019SPROSpero Therapeutics ...Pottage John C JrDirectorOption ExerciseA10.676,07364,7996,073
Jun 05 2019SPROSpero Therapeutics ...THOMAS FRANK EDirectorOption ExerciseA10.676,07364,7996,073
Jun 05 2019SPROSpero Therapeutics ...FORMELA JEAN FRANCOISDirectorOption ExerciseA10.676,07364,7996,073
Jun 05 2019SPROSpero Therapeutics ...Deshpande MilindDirectorOption ExerciseA10.676,07364,7996,073
Jun 05 2019SPROSpero Therapeutics ...VINK PATRICK V.J.J.DirectorOption ExerciseA10.676,07364,7996,073
Mar 29 2019SPROSpero Therapeutics ...Smith CynthiaDirectorOption ExerciseA12.8112,146155,59012,146
Jan 02 2019SPROSpero Therapeutics ...Parr Thomas R JRChief Scientific Of ...Option ExerciseA6.2635,000219,10035,000
Jan 02 2019SPROSpero Therapeutics ...Melnick David A.Chief Medical Offic ...Option ExerciseA6.2665,000406,90065,000
Jan 02 2019SPROSpero Therapeutics ...Larkin CristinaChief Operating Off ...Option ExerciseA6.2665,000406,90065,000
Jan 02 2019SPROSpero Therapeutics ...Sendek JoelChief Financial Off ...Option ExerciseA6.2665,000406,90065,000
Jan 02 2019SPROSpero Therapeutics ...Mahadevia AnkitCEO and PresidentOption ExerciseA6.26180,0001,126,800180,000
Sep 21 2018SPROSpero Therapeutics ...Pottage John C JrDirectorOption ExerciseA10.2512,146124,49712,146
Jul 17 2018SPROSpero Therapeutics ...GLAXOSMITHKLINE PLC10% OwnerBuyP12.5080,0001,000,0001,934,0061.9 M to 1.9 M (+4.31 %)
Jul 06 2018SPROSpero Therapeutics ...Larkin CristinaChief Operating Off ...Option ExerciseM5.904,00023,60020,434
Jul 06 2018SPROSpero Therapeutics ...Larkin CristinaChief Operating Off ...SellS17.504,00070,0001,5005.5 K to 1.5 K (-72.73 %)
Jul 06 2018SPROSpero Therapeutics ...Larkin CristinaChief Operating Off ...BuyM5.904,00023,6005,5001.5 K to 5.5 K (+266.67 %)
Jul 06 2018SPROSpero Therapeutics ...Sendek JoelChief Financial Off ...Option ExerciseM5.902,00011,800165,833
Jul 06 2018SPROSpero Therapeutics ...Sendek JoelChief Financial Off ...SellS17.502,00035,00015,18117.2 K to 15.2 K (-11.64 %)
Jul 06 2018SPROSpero Therapeutics ...Sendek JoelChief Financial Off ...BuyM5.902,00011,80017,18115.2 K to 17.2 K (+13.17 %)
Jul 06 2018SPROSpero Therapeutics ...Mahadevia AnkitSee RemarksOption ExerciseM5.901,6009,440118,888
Jul 06 2018SPROSpero Therapeutics ...Mahadevia AnkitSee RemarksOption ExerciseM5.903,07618,148120,488
Jul 06 2018SPROSpero Therapeutics ...Mahadevia AnkitSee RemarksSellS17.922003,58465,81766 K to 65.8 K (-0.30 %)
Jul 06 2018SPROSpero Therapeutics ...Mahadevia AnkitSee RemarksSellS17.902003,58066,01766.2 K to 66 K (-0.30 %)
Jul 06 2018SPROSpero Therapeutics ...Mahadevia AnkitSee RemarksSellS17.711001,77166,21766.3 K to 66.2 K (-0.15 %)
Jul 06 2018SPROSpero Therapeutics ...Mahadevia AnkitSee RemarksSellS17.621001,76266,31766.4 K to 66.3 K (-0.15 %)
Jul 06 2018SPROSpero Therapeutics ...Mahadevia AnkitSee RemarksSellS17.584007,03266,41766.8 K to 66.4 K (-0.60 %)
Jul 06 2018SPROSpero Therapeutics ...Mahadevia AnkitSee RemarksSellS17.551001,75566,81766.9 K to 66.8 K (-0.15 %)
Jul 06 2018SPROSpero Therapeutics ...Mahadevia AnkitSee RemarksSellS17.505008,75066,91767.4 K to 66.9 K (-0.74 %)
Jul 06 2018SPROSpero Therapeutics ...Mahadevia AnkitSee RemarksBuyM5.901,6009,44067,41765.8 K to 67.4 K (+2.43 %)
Jul 06 2018SPROSpero Therapeutics ...Mahadevia AnkitSee RemarksSellS17.623,07654,20465,81768.9 K to 65.8 K (-4.46 %)
Jul 06 2018SPROSpero Therapeutics ...Mahadevia AnkitSee RemarksBuyM5.903,07618,14868,89365.8 K to 68.9 K (+4.67 %)
Jul 06 2018SPROSpero Therapeutics ...Larkin CristinaChief Operating Off ...Option ExerciseM5.904,00023,60020,434
Jul 06 2018SPROSpero Therapeutics ...Larkin CristinaChief Operating Off ...SellS17.504,00070,0001,5005.5 K to 1.5 K (-72.73 %)
Jul 06 2018SPROSpero Therapeutics ...Larkin CristinaChief Operating Off ...BuyM5.904,00023,6005,5001.5 K to 5.5 K (+266.67 %)
Jul 06 2018SPROSpero Therapeutics ...Sendek JoelChief Financial Off ...Option ExerciseM5.902,00011,800165,833
Jul 06 2018SPROSpero Therapeutics ...Sendek JoelChief Financial Off ...SellS17.502,00035,00015,18117.2 K to 15.2 K (-11.64 %)
Jul 06 2018SPROSpero Therapeutics ...Sendek JoelChief Financial Off ...BuyM5.902,00011,80017,18115.2 K to 17.2 K (+13.17 %)
Jul 06 2018SPROSpero Therapeutics ...Mahadevia AnkitSee RemarksOption ExerciseM5.901,6009,440118,888
Jul 06 2018SPROSpero Therapeutics ...Mahadevia AnkitSee RemarksOption ExerciseM5.903,07618,148120,488
Jul 06 2018SPROSpero Therapeutics ...Mahadevia AnkitSee RemarksSellS17.922003,58465,81766 K to 65.8 K (-0.30 %)
Jul 06 2018SPROSpero Therapeutics ...Mahadevia AnkitSee RemarksSellS17.902003,58066,01766.2 K to 66 K (-0.30 %)
Jul 06 2018SPROSpero Therapeutics ...Mahadevia AnkitSee RemarksSellS17.711001,77166,21766.3 K to 66.2 K (-0.15 %)
Jul 06 2018SPROSpero Therapeutics ...Mahadevia AnkitSee RemarksSellS17.621001,76266,31766.4 K to 66.3 K (-0.15 %)
Jul 06 2018SPROSpero Therapeutics ...Mahadevia AnkitSee RemarksSellS17.584007,03266,41766.8 K to 66.4 K (-0.60 %)
Jul 06 2018SPROSpero Therapeutics ...Mahadevia AnkitSee RemarksSellS17.551001,75566,81766.9 K to 66.8 K (-0.15 %)
Jul 06 2018SPROSpero Therapeutics ...Mahadevia AnkitSee RemarksSellS17.505008,75066,91767.4 K to 66.9 K (-0.74 %)
Jul 06 2018SPROSpero Therapeutics ...Mahadevia AnkitSee RemarksBuyM5.901,6009,44067,41765.8 K to 67.4 K (+2.43 %)
Jul 06 2018SPROSpero Therapeutics ...Mahadevia AnkitSee RemarksSellS17.623,07654,20465,81768.9 K to 65.8 K (-4.46 %)
Jul 06 2018SPROSpero Therapeutics ...Mahadevia AnkitSee RemarksBuyM5.903,07618,14868,89365.8 K to 68.9 K (+4.67 %)
Jun 06 2018SPROSpero Therapeutics ...THOMAS FRANK EDirectorOption ExerciseA11.546,07370,0826,073
Jun 06 2018SPROSpero Therapeutics ...FORMELA JEAN FRANCOISDirectorOption ExerciseA11.546,07370,0826,073
Jun 06 2018SPROSpero Therapeutics ...SOUTHWELL DAVID PDirectorOption ExerciseA11.546,07370,0826,073
Jun 06 2018SPROSpero Therapeutics ...Breum CasperDirectorOption ExerciseA11.546,07370,0826,073
Jun 06 2018SPROSpero Therapeutics ...Deshpande MilindDirectorOption ExerciseA11.546,07370,0826,073
Jun 06 2018SPROSpero Therapeutics ...VINK PATRICK V.J.J.DirectorOption ExerciseA11.546,07370,0826,073
Mar 30 2018SPROSpero Therapeutics ...SOUTHWELL DAVID PDirectorOption ExerciseA14.2512,146173,08112,146
Jan 05 2018SPROSpero Therapeutics ...Melnick David A.Chief Medical Offic ...Option ExerciseA12.14135,0001,638,900135,000
Dec 15 2017SPROSpero Therapeutics ...Larkin CristinaChief Operating Off ...Option ExerciseA11.6362,540727,34062,540
Dec 15 2017SPROSpero Therapeutics ...Sendek JoelChief Financial Off ...Option ExerciseA11.6327,795323,25627,795
Dec 15 2017SPROSpero Therapeutics ...Parr Thomas R JRChief Scientific Of ...Option ExerciseA11.6336,134420,23836,134
Dec 15 2017SPROSpero Therapeutics ...Mahadevia AnkitSee RemarksOption ExerciseA11.63125,0791,454,669125,079
Nov 07 2017SPROSpero Therapeutics ...GLAXOSMITHKLINE PLC10% OwnerOption ExerciseC0.003,683,04500
Nov 07 2017SPROSpero Therapeutics ...GLAXOSMITHKLINE PLC10% OwnerOption ExerciseC0.001,250,00000
Nov 07 2017SPROSpero Therapeutics ...GLAXOSMITHKLINE PLC10% OwnerOption ExerciseC0.00982,90600
Nov 07 2017SPROSpero Therapeutics ...GLAXOSMITHKLINE PLC10% OwnerOption ExerciseC0.001,483,78400
Nov 07 2017SPROSpero Therapeutics ...GLAXOSMITHKLINE PLC10% OwnerBuyP14.00428,5715,999,9941,854,0061.4 M to 1.9 M (+30.07 %)
Nov 07 2017SPROSpero Therapeutics ...GLAXOSMITHKLINE PLC10% OwnerBuyC0.00606,02401,425,435819.4 K to 1.4 M (+73.96 %)
Nov 07 2017SPROSpero Therapeutics ...GLAXOSMITHKLINE PLC10% OwnerBuyC0.00328,9920819,411490.4 K to 819.4 K (+67.08 %)
Nov 07 2017SPROSpero Therapeutics ...GLAXOSMITHKLINE PLC10% OwnerBuyC0.00246,2720490,419244.1 K to 490.4 K (+100.87 %)
Nov 07 2017SPROSpero Therapeutics ...GLAXOSMITHKLINE PLC10% OwnerBuyC0.00244,1470244,1470 to 244.1 K
Nov 07 2017SPROSpero Therapeutics ...FORMELA JEAN FRANCOISDirectorOption ExerciseC0.003,662,17800
Nov 07 2017SPROSpero Therapeutics ...FORMELA JEAN FRANCOISDirectorOption ExerciseC0.003,119,63300
Nov 07 2017SPROSpero Therapeutics ...FORMELA JEAN FRANCOISDirectorOption ExerciseC0.001,250,00000
Nov 07 2017SPROSpero Therapeutics ...FORMELA JEAN FRANCOISDirectorOption ExerciseC0.00982,90600
Nov 07 2017SPROSpero Therapeutics ...FORMELA JEAN FRANCOISDirectorOption ExerciseC0.001,492,64500
Nov 07 2017SPROSpero Therapeutics ...FORMELA JEAN FRANCOISDirectorBuyP14.00428,5715,999,9942,408,1282 M to 2.4 M (+21.65 %)
Nov 07 2017SPROSpero Therapeutics ...FORMELA JEAN FRANCOISDirectorBuyC0.00602,58901,979,5571.4 M to 2 M (+43.76 %)
Nov 07 2017SPROSpero Therapeutics ...FORMELA JEAN FRANCOISDirectorBuyC0.00513,31801,376,968863.7 K to 1.4 M (+59.44 %)
Nov 07 2017SPROSpero Therapeutics ...FORMELA JEAN FRANCOISDirectorBuyC0.00328,9920863,650534.7 K to 863.7 K (+61.53 %)
Nov 07 2017SPROSpero Therapeutics ...FORMELA JEAN FRANCOISDirectorBuyC0.00246,2720534,658288.4 K to 534.7 K (+85.40 %)
Nov 07 2017SPROSpero Therapeutics ...FORMELA JEAN FRANCOISDirectorBuyC0.00245,6050288,38642.8 K to 288.4 K (+574.10 %)
Nov 07 2017SPROSpero Therapeutics ...Goyal VikasDirectorOption ExerciseC0.003,683,04500

Page:   1 2 next >